Global Gastroenterology Ambulatory Surgery Center Market Size (2024 - 2029)

The gastroenterology ambulatory surgery center market is anticipated to experience growth over the forecast period, driven by several key factors. The market's expansion is influenced by the increasing incidence of gastrointestinal disorders, which has been rising in various regions, including newly industrialized areas. The shift in preference from hospitals to ambulatory surgical centers is also contributing to the market's growth. Additionally, the market is benefiting from the relaxation of COVID-19 restrictions, which had previously hindered its expansion. The ongoing research and development efforts by biopharmaceutical companies further support the market's potential growth, as positive outcomes from clinical trials may lead to increased opportunities in this sector.

Market Size of Global Gastroenterology Ambulatory Surgery Center Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Gastroenterology Ambulatory Surgery Center Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 7.00 %
Fastest Growing Market North America
Largest Market South America

Major Players

Global Gastroenterology Ambulatory Surgery Center Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Gastroenterology Ambulatory Surgery Center Market Analysis

The Gastroenterology Ambulatory Surgery Center Market is projected to register a CAGR of 7% during the forecast period (2022-2027).

The COVID-19 pandemic seemed to negatively impact the market's growth during the pandemic period. This factor is mainly due to the sudden imposition of lockdowns across the globe, which resulted in a lack of workforce & staff-also, prioritizing only the emergency cases negatively impacted the market's growth. For instance, in April 2020, the Centers for Medicare & Medicaid Services announced recommendations for postponing non-essential surgeries and other procedures with the help of a tiered framework collaboration with medical societies and associations. Thus, operational restrictions such as mandates to stop or postpone elective surgeries during the COVID-19 pandemic negatively impacted the market's growth. However, the relaxations of such strict restrictions during the post-pandemic period provided lucrative opportunities for the market players as the patient influx will increase gradually.

The factors such as growing incidences of gastrointestinal disorders are the major factors contributing to the market's growth. For instance, a research study published in the Journal of Anus, Rectum, and Colon in 2020 showed around 180,000 patients with ulcerative colitis in Japan. In addition, the incidence and prevalence in Latin America have been rising in newly industrialized regions. According to a research study published in Therapeutic Advances in Gastroenterology Journal 2020, the incidence and prevalence of ulcerative colitis (UC) in Latin America were between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000, respectively. Research studies showing the increasing prevalence of various gastrointestinal disorders are expected to drive the market's growth.

Moreover, shifting preference toward ambulatory surgical centers from hospitals is also expected to boost the market's growth. For instance, according to the Medicare Payment Advisory Commission and VMG Health Data published in June 2021, the outpatient surgical volume in ambulatory surgical centers has increased over the last decade. Other driving factors include the rising surgical treatments and hospitalizations due to GI diseases and increasing R&D investments by biopharmaceutical companies. For instance, as of August 2022, there were around 35967 ongoing clinical trials related to gastrointestinal diseases across different phases of development, as per the National Clinical Trial (NCT) registry. The positive outcomes from these studies can create new opportunities for an increase in gastroenterology ambulatory surgery center over the forecast period.

Thus, due to the abovementioned factors, the gastroenterology ambulatory surgical center is expected to grow during the forecast period.

Gastroenterology Ambulatory Surgery Center Industry Segmentation

As per the scope of the report, Gastroenterology is the study of normal function and diseases of the esophagus, stomach and small intestines, colon, and others. The Gastroenterology Ambulatory Surgery Center Market is segmented by Services (Diagnostic Services, Surgical Services), Ownership (Hospital-Affiliated, Freestanding, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (USD million) for the above segments.

By Services
Diagnostic Services
Surgical Services
By Ownership
Hospital-Affiliated
Freestanding
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Gastroenterology Ambulatory Surgery Center Market Size Summary

The Gastroenterology Ambulatory Surgery Center Market is poised for significant growth, driven by an increasing prevalence of gastrointestinal disorders and a shift in preference towards outpatient surgical facilities. The market experienced a temporary setback during the COVID-19 pandemic due to operational restrictions and the postponement of non-essential surgeries. However, the easing of these restrictions has opened up new opportunities for market players as patient influx begins to rise. The growing incidence of conditions such as ulcerative colitis, particularly in newly industrialized regions, is a key factor propelling market expansion. Additionally, the rise in surgical treatments and hospitalizations due to gastrointestinal diseases, coupled with increased research and development investments by biopharmaceutical companies, is expected to further stimulate market growth.

The freestanding segment, particularly physician-owned ambulatory surgery centers, is anticipated to dominate the market due to its ability to offer enhanced control over clinical environments and quality of care. The United States is expected to lead the global market, supported by a high incidence of gastrointestinal issues and a robust adoption rate of ambulatory surgical centers. The presence of major market players and advanced technologies in the region further bolsters its market position. Innovative product launches and favorable healthcare infrastructure are also contributing to regional market growth. The market is characterized by fragmentation and competitiveness, with several key players such as Alfa Surgery Center, LLC, and Koninklijke Philips N.V. leading the charge.

Explore More

Global Gastroenterology Ambulatory Surgery Center Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing incidences of gastrointestinal diorders

      2. 1.2.2 Rising preferences for ambulatory services

    3. 1.3 Market Restraints

      1. 1.3.1 Regulatory uncertainaties

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Services

      1. 2.1.1 Diagnostic Services

      2. 2.1.2 Surgical Services

    2. 2.2 By Ownership

      1. 2.2.1 Hospital-Affiliated

      2. 2.2.2 Freestanding

      3. 2.2.3 Others

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Gastroenterology Ambulatory Surgery Center Market Size FAQs

The Global Gastroenterology Ambulatory Surgery Center Market is projected to register a CAGR of 7% during the forecast period (2024-2029)

Alfa Surgery Center, LLC, Koninklijke Philips N.V., Ohio Gastroenterology Group Inc, Gastro Health LLC and Ontario Advanced Surgery Center are the major companies operating in the Global Gastroenterology Ambulatory Surgery Center Market.

Gastroenterology Ambulatory Surgery Center Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)